2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1407182041 MD
Verify on CMS →

LILY KWATAMPORA, MD

Endocrinology, Diabetes & Metabolism Physician in GOSHEN, Indiana. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 156 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
27%
generic claims · 73% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$1.7K
87 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

LILY KWATAMPORA, MD filed 1,281 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in GOSHEN, Indiana, prescribing 27% generic.

1K
Part D claims, 2023
27%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

LILY KWATAMPORA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,281 Top 22% higher than 78% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

LILY KWATAMPORA, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about LILY KWATAMPORA, MD?

Quality data not reported

NPI registry status

Active

Issued 11/01/2009

NPI 1407182041

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

1,281 51% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

Specialty distribution in Indiana

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Indiana providers

Indiana providers

Endocrinology, Diabetes & Metabolism Physician share within Indiana

1. Endocrinology, Diabetes & Metabolism Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Endocrinology, Diabetes & Metabolism Physician share within Indiana

Specialty board-certification context

Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate

Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

LILY KWATAMPORA, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 2012 S MAIN ST, GOSHEN, IN, 46526, with a listed phone of (574) 500-2010. NPI 1407182041 was issued on 11/01/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KWATAMPORA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,281 prescription claims written by this provider, covering 156 Medicare beneficiaries and totaling roughly $1.1 million in drug spend, split 73% brand-name and 27% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2012 S MAIN ST
GOSHEN, IN 46526

Provider Details

NPI 1407182041
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials MD
Gender Female
NPI Issued 11/01/2009

Hospital and facility affiliations

Facilities where LILY KWATAMPORA, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

GOSHEN HEALTH SYSTEM INC
GOSHEN, IN

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for LILY KWATAMPORA, MD. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Tandem Diabetes Care, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Brand-heavy

LILY KWATAMPORA, MD — brand share 73.0%
Specialty average (est.)

73% brand-name claims vs 27% generic, on 1,281 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,281
Total Claims
$1.1M
Total Drug Cost
156
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,373
Total Day Supply
69,234
Brand vs Generic
73% brand / 27% generic
Brand Drug Cost
$1.0M
Generic Drug Cost
$4K

Patient Demographics

Average Patient Age
68.2 years
Avg HCC Risk Score
1.85
Gender Split
64% female / 36% male
Age Distribution
<65: 36, 65-74: 84, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What LILY KWATAMPORA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ozempic
Semaglutide
133
Soliqua 100-33
Insulin Glargine/Lixisenatide
78
Tresiba Flextouch U-100
Insulin Degludec
60
Jardiance
Empagliflozin
56
Novolog Flexpen
Insulin Aspart
54
Trulicity
Dulaglutide
48
Unithroid
Levothyroxine Sodium
46
Farxiga
Dapagliflozin Propanediol
42
Methimazole
41
Novolog
Insulin Aspart
31

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Endocrinology, Diabetes & Metabolism Physician Overview

How LILY KWATAMPORA, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

LILY KWATAMPORA, MD's 1,281 claims are below the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as KWATAMPORA.

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is LILY KWATAMPORA, MD's specialty?
LILY KWATAMPORA, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in GOSHEN, Indiana. Credentials: MD.
How much does LILY KWATAMPORA, MD prescribe under Medicare Part D?
In 2023, LILY KWATAMPORA, MD wrote 1,281 Medicare Part D claims totaling $1.1M in drug costs for 156 beneficiaries.
Where is LILY KWATAMPORA, MD located?
LILY KWATAMPORA, MD is located at 2012 S MAIN ST, GOSHEN, IN, 46526. Phone: (574) 500-2010.
What is LILY KWATAMPORA, MD's NPI number?
LILY KWATAMPORA, MD's National Provider Identifier (NPI) is 1407182041, issued on 11/01/2009.
Does LILY KWATAMPORA, MD prescribe more brand-name or generic drugs?
LILY KWATAMPORA, MD's prescribing is 73% brand-name and 27% generic drugs by claim count, with $1.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US?
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does LILY KWATAMPORA, MD prescribe most often?
Based on 2023 Medicare Part D data, LILY KWATAMPORA, MD's most frequently prescribed drugs include Ozempic, Soliqua 100-33, Tresiba Flextouch U-100. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does LILY KWATAMPORA, MD accept Medicare?
LILY KWATAMPORA, MD appears in CMS Medicare data with 1,281 Part D claims and 156 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify LILY KWATAMPORA, MD's credentials?
LILY KWATAMPORA, MD's NPI is 1407182041 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology